Patterns of medication errors involving pediatric population reported to the French Medication Error Guichet.
Adverse Drug Reaction Reporting Systems
Child
Drug-Related Side Effects and Adverse Reactions
France
Infant
Medication Errors
Multivariate Analysis
Patient Safety
Pharmacoepidemiology
Pharmacovigilance
Retrospective Studies
Journal
Pharmacy practice
ISSN: 1885-642X
Titre abrégé: Pharm Pract (Granada)
Pays: Spain
ID NLM: 101530029
Informations de publication
Date de publication:
Historique:
received:
29
03
2021
accepted:
30
05
2021
entrez:
5
7
2021
pubmed:
6
7
2021
medline:
6
7
2021
Statut:
ppublish
Résumé
Medication error is a global threat to patient safety, particularly in pediatrics. Yet, this issue remains understudied in this population, in both hospital and community settings. To characterize medication errors involving pediatrics reported to the French Medication Error Guichet, and compare them with medication errors in adults, in each of the hospital and community settings. This was a retrospective secondary data analysis of medication errors reported throughout 2013-2017. Descriptive and multivariate analyses were performed to compare actual and potential medication error reports between pediatrics (aged <18 years) and adults (aged >18 and <60 years). Two subanalyses of actual medication errors with adverse drug reaction (ADR), and serious ADR were conducted. We analyzed 4,718 medication error reports. In pediatrics, both in hospital (n=791) and community (n=1,541) settings, antibacterials for systemic use (n=121, 15.7%; n=157, 10.4%, respectively) and wrong dose error type (n=391, 49.6%; n=549, 35.7%, respectively) were frequently reported in medication errors. These characteristics were also significantly more likely to be associated with reported errors in pediatrics compared with adults. In the hospital setting, analgesics (adjusted odds ratio (aOR)=1.59; 95% confidence interval (CI) 1.03:2.45), and blood substitutes and perfusion solutions (aOR=3.74; 95%CI 2.24:6.25) were more likely to be associated with reported medication errors in pediatrics; the latter drug class (aOR=3.02; 95%CI 1.59:5.72) along with wrong technique (aOR=2.28; 95%CI 1.01:5.19) and wrong route (aOR=2.74; 95%CI 1.22:6.15) error types related more to reported medication errors with serious ADR in pediatrics. In the community setting, the most frequently reported pediatric medication errors involved vaccines (n=389, 25.7%). Psycholeptics (aOR=2.42; 95%CI 1.36:4.31) were more likely to be associated with reported medication errors with serious ADR in pediatrics. Wrong technique error type (aOR=2.71; 95%CI 1.47:5.00) related more to reported medication errors with ADR in pediatrics. We identified pediatric-specific medication error patterns in the hospital and community settings. Our findings inform focused error prevention measures, and pave the way for interventional research targeting the needs of this population.
Sections du résumé
BACKGROUND
BACKGROUND
Medication error is a global threat to patient safety, particularly in pediatrics. Yet, this issue remains understudied in this population, in both hospital and community settings.
OBJECTIVES
OBJECTIVE
To characterize medication errors involving pediatrics reported to the French Medication Error Guichet, and compare them with medication errors in adults, in each of the hospital and community settings.
METHODS
METHODS
This was a retrospective secondary data analysis of medication errors reported throughout 2013-2017. Descriptive and multivariate analyses were performed to compare actual and potential medication error reports between pediatrics (aged <18 years) and adults (aged >18 and <60 years). Two subanalyses of actual medication errors with adverse drug reaction (ADR), and serious ADR were conducted.
RESULTS
RESULTS
We analyzed 4,718 medication error reports. In pediatrics, both in hospital (n=791) and community (n=1,541) settings, antibacterials for systemic use (n=121, 15.7%; n=157, 10.4%, respectively) and wrong dose error type (n=391, 49.6%; n=549, 35.7%, respectively) were frequently reported in medication errors. These characteristics were also significantly more likely to be associated with reported errors in pediatrics compared with adults. In the hospital setting, analgesics (adjusted odds ratio (aOR)=1.59; 95% confidence interval (CI) 1.03:2.45), and blood substitutes and perfusion solutions (aOR=3.74; 95%CI 2.24:6.25) were more likely to be associated with reported medication errors in pediatrics; the latter drug class (aOR=3.02; 95%CI 1.59:5.72) along with wrong technique (aOR=2.28; 95%CI 1.01:5.19) and wrong route (aOR=2.74; 95%CI 1.22:6.15) error types related more to reported medication errors with serious ADR in pediatrics. In the community setting, the most frequently reported pediatric medication errors involved vaccines (n=389, 25.7%). Psycholeptics (aOR=2.42; 95%CI 1.36:4.31) were more likely to be associated with reported medication errors with serious ADR in pediatrics. Wrong technique error type (aOR=2.71; 95%CI 1.47:5.00) related more to reported medication errors with ADR in pediatrics.
CONCLUSIONS
CONCLUSIONS
We identified pediatric-specific medication error patterns in the hospital and community settings. Our findings inform focused error prevention measures, and pave the way for interventional research targeting the needs of this population.
Identifiants
pubmed: 34221205
doi: 10.18549/PharmPract.2021.2.2360
pii: pharmpract-19-2360
pmc: PMC8234707
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2360Informations de copyright
Copyright: © The Authors.
Déclaration de conflit d'intérêts
CONFLICT OF INTEREST The Authors declare that there is no conflict of interest.
Références
Expert Opin Drug Saf. 2013 Nov;12(6):805-14
pubmed: 23931332
Arch Dis Child. 2019 Jun;104(6):596-599
pubmed: 30154183
J Pediatr Pharmacol Ther. 2009 Jul;14(3):127-31
pubmed: 23055900
J Postgrad Med. 2012 Jan-Mar;58(1):47-53
pubmed: 22387648
Pharmacoepidemiol Drug Saf. 2018 Aug;27(8):902-911
pubmed: 29740912
Pediatrics. 2013 May;131(5):e1405-14
pubmed: 23629608
Jt Comm J Qual Patient Saf. 2008 Jan;34(1):36-45
pubmed: 18277800
Jt Comm J Qual Saf. 2004 Sep;30(9):471-9
pubmed: 15469124
Paediatr Drugs. 2020 Oct;22(5):551-560
pubmed: 32627136
J Korean Med Sci. 2015 Apr;30(4):371-7
pubmed: 25829803
Drug Saf. 2007;30(12):1111-25
pubmed: 18035864
Ambul Pediatr. 2007 Sep-Oct;7(5):383-9
pubmed: 17870647
Eur J Clin Pharmacol. 2008 Aug;64(8):769-74
pubmed: 18512053
Arch Dis Child. 2011 Jun;96(6):581-6
pubmed: 21444297
J Paediatr Child Health. 2014 Jan;50(1):71-7
pubmed: 24397451
Pediatrics. 2015 Jun;135(6):1027-35
pubmed: 25941305
Am J Med Qual. 2014 Jan-Feb;29(1):61-9
pubmed: 23656705
Drug Saf. 2019 Jan;42(1):13-25
pubmed: 30117051
West J Nurs Res. 2015 Oct;37(10):1295-307
pubmed: 25656875
Arch Dis Child. 2015 Oct;100(10):960-5
pubmed: 25977563
Mayo Clin Proc. 2014 Aug;89(8):1116-25
pubmed: 24981217
Integr Pharm Res Pract. 2015 Nov 05;4:153-165
pubmed: 29354530
J Clin Pharmacol. 2003 Jul;43(7):760-7
pubmed: 12856391
Eur J Pediatr. 2019 Dec;178(12):1923-1927
pubmed: 31506723
Qual Saf Health Care. 2007 Apr;16(2):116-26
pubmed: 17403758
JAMA. 2001 Apr 25;285(16):2114-20
pubmed: 11311101
Vaccine. 2009 Jun 12;27(29):3890-6
pubmed: 19442422
Clin Toxicol (Phila). 2014 Sep-Oct;52(8):880-8
pubmed: 25175900
Drug Saf. 2004;27(9):661-70
pubmed: 15230647
Drug Saf. 2019 Dec;42(12):1423-1436
pubmed: 31410745
PLoS One. 2016 Dec 1;11(12):e0167204
pubmed: 27907072
Qual Saf Health Care. 2007 Oct;16(5):369-77
pubmed: 17913779
Clin Toxicol (Phila). 2011 Jul;49(6):485-91
pubmed: 21824059
Eur J Pediatr. 2017 Dec;176(12):1697-1705
pubmed: 28965285
Qual Saf Health Care. 2006 Jun;15(3):174-8
pubmed: 16751466
J Clin Nurs. 2018 Mar;27(5-6):892-905
pubmed: 28906047
JAMA. 2000 Jul 5;284(1):95-7
pubmed: 10872022
Pediatrics. 2017 Jul;140(1):
pubmed: 28759396
Pediatrics. 2014 Nov;134(5):867-76
pubmed: 25332497
J Paediatr Child Health. 2009 May;45(5):304-9
pubmed: 19320803